{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:17:21Z","timestamp":1785403041922,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.euf.2025.04.028","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T07:22:02Z","timestamp":1745824922000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis"],"prefix":"10.1016","volume":"12","author":[{"given":"Nikolaos","family":"Pyrgidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald Bastian","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozefina","family":"Casuscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Tzelves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Katsimperis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ciavarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Sokolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Ramos","family":"Belinchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Ca\u00f1o","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Umari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Wong Ho","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Del","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.04.028_b0005","doi-asserted-by":"crossref","unstructured":"Pyrgidis N, Volz Y, Ebner B, et al. Evolution of robotic urology in clinical practice from the beginning to now: results from the GRAND Study Register. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2024.08.004.","DOI":"10.1016\/j.euf.2024.08.004"},{"key":"10.1016\/j.euf.2025.04.028_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00345-023-04742-z","article-title":"The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data","volume":"42","author":"Pyrgidis","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00345-024-04970-x","article-title":"Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center","volume":"42","author":"Pellegrino","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0020","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1001\/jama.2022.7393","article-title":"Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer: a randomized clinical trial","volume":"327","author":"Catto","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2025.04.028_b0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.euf.2023.05.002","article-title":"Complications after radical cystectomy: a systematic review and meta-analysis of randomized controlled trials with a meta-regression analysis","volume":"9","author":"Katsimperis","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.04.028_b0030","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0035","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1200\/JCO.2016.69.2327","article-title":"Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic","volume":"35","author":"Kulkarni","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4_suppl","key":"10.1016\/j.euf.2025.04.028_b0040","article-title":"Phase 3 KEYNOTE-992 study of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with muscle-invasive bladder cancer (MIBC)","volume":"42","author":"Fujii","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.04.028_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2022.04.017","article-title":"Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial","volume":"82","author":"Hall","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.urolonc.2021.01.013","article-title":"Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer","volume":"40","author":"Feldman","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2025.04.028_b0060","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.juro.2010.08.007","article-title":"Early complications of cystectomy after high dose pelvic radiation","volume":"184","author":"Eisenberg","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2023.04.027","article-title":"Guidelines for reporting observational research in urology: the importance of clear reference to causality","volume":"84","author":"Vickers","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0070","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2025.04.028_b0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00345-024-05196-7","article-title":"Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review","volume":"42","author":"Kaufmann","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2010.05.041","article-title":"Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?","volume":"58","author":"Giannarini","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0090","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euf.2017.02.014","article-title":"Validation of the Clavien-Dindo grading system in urology by the European Association of Urology Guidelines Ad Hoc Panel","volume":"4","author":"Mitropoulos","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.04.028_b0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.04.028_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JU.0000000000001696","article-title":"Complications and outcomes of salvage cystectomy after trimodality therapy","volume":"206","author":"Pieretti","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2015.07.038","article-title":"A single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL)","volume":"69","author":"Khan","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.euo.2019.11.005","volume":"3","author":"Bruins","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.04.028_b0115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0120","first-page":"161","article-title":"The case for salvage cystectomy after pelvic radiation","volume":"68","author":"Calderone","year":"2016","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.euf.2025.04.028_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.eururo.2008.07.018","article-title":"Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience","volume":"55","author":"Donat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.juro.2011.09.159","article-title":"Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer","volume":"187","author":"Eswara","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1464-410X.2004.05034.x","article-title":"Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer","volume":"94","author":"Nieuwenhuijzen","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.04.028_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.euf.2015.06.009","article-title":"Cost analysis of the enhanced recovery after surgery protocol in patients undergoing radical cystectomy for bladder cancer","volume":"2","author":"Nabhani","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.04.028_b0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000496347","article-title":"In-hospital outcomes after radical cystectomy for bladder cancer: comparing national trends in the United States and Germany from 2006 to 2014","volume":"102","author":"Groeben","year":"2019","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2025.04.028_b0150","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.clgc.2023.03.004","article-title":"The short- and long-term effect of radical cystectomy in frail patients with bladder cancer","volume":"21","author":"Pyrgidis","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2025.04.028_b0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00345-024-04887-5","article-title":"The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study","volume":"42","author":"Pyrgidis","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.euf.2020.01.007","article-title":"Management of muscle-invasive bladder cancer in the 2020s: challenges and perspectives","volume":"6","author":"Gakis","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.04.028_b0165","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.euf.2020.07.002","article-title":"Nomogram predicting bladder cancer-specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium","volume":"7","author":"Mir","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.04.028_b0170","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/ua.ua_50_23","article-title":"Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: single-center experience","volume":"15","author":"Fallatah","year":"2023","journal-title":"Urol Ann"},{"key":"10.1016\/j.euf.2025.04.028_b0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00345-024-04892-8","article-title":"Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer","volume":"42","author":"Swinton","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0180","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/14737140.2023.2257389","article-title":"Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future","volume":"23","author":"Koga","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.euf.2025.04.028_b0185","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.6_suppl.TPS586","article-title":"INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer\u2014SWOG\/NRG1806","volume":"38","author":"Singh","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.04.028_b0190","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1200\/JCO.2021.39.15_suppl.4504","article-title":"Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): a multicenter phase 2 trial","volume":"39","author":"Balar","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.04.028_b0195","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS4586","article-title":"A phase 3, multicenter, randomized study evaluating the efficacy of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive urothelial carcinoma of the bladder","volume":"39","author":"Williams","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.04.028_b0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.euf.2022.12.012","article-title":"Efficacy and safety of pembrolizumab (MK-3475) in combination with chemoradiotherapy versus chemoradiotherapy alone in muscle-invasive bladder cancer: the MK-3475-992\/KEYNOTE-992 trial","volume":"9","author":"Tissot","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.04.028_b0205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MOU.0000000000001220","article-title":"Bladder sparing options for muscle-invasive bladder cancer","volume":"34","author":"Laukhtina","year":"2024","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euf.2025.04.028_b0210","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/s41591-023-02568-1","article-title":"Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial","volume":"29","author":"Galsky","year":"2023","journal-title":"Nat Med"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925001026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925001026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:58:14Z","timestamp":1770145094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925001026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2405456925001026"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.04.028","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}